Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-019-01934-6
Abstract: The approved dose of oral anticoagulant rivaroxaban for patients with non-valvular atrial fibrillation (NVAF) in Japan is 15 mg once daily (od) in patients whose creatinine clearance is ≥ 50 mL/min, but recent real-world studies have demonstrated… read more here.
Keywords: atrial fibrillation; real world; valvular atrial; non valvular ... See more keywords
Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Cardiovascular Drugs"
DOI: 10.1007/s40256-018-0293-0
Abstract: IntroductionEffectiveness of oral anticoagulants (OACs) is critically dependent on patients’ adherence to intake regimens. We studied the relative impact of attributes related to effectiveness, safety, convenience, and costs on the value of OAC therapy from… read more here.
Keywords: atrial fibrillation; valvular atrial; non valvular; therapy ... See more keywords
Real-world persistence with direct oral anticoagulants (DOACs) in naïve patients with non-valvular atrial fibrillation.
Sign Up to like & getrecommendations! Published in 2019 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2019.04.061
Abstract: BACKGROUND Anticoagulation therapy is central for the management of stroke in patients with non-valvular atrial fibrillation (NVAF). Persistence with oral anticoagulation is essential to prevent thromboembolic complications. METHODS We performed a population-based retrospective cohort study… read more here.
Keywords: valvular atrial; oral anticoagulants; patients non; non valvular ... See more keywords
Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of cardiology"
DOI: 10.1016/j.jjcc.2016.11.009
Abstract: BACKGROUND Adherence to medication plays an important role in the prevention of morbidity and mortality in non-valvular atrial fibrillation (NVAF) patients. The aim of this study is to assess adherence to medication and risk factors… read more here.
Keywords: valvular atrial; non valvular; non adherence; adherence medication ... See more keywords
Discrepancies between the use of MDRD-4 IDMS and CKD-EPI equations, instead of the Cockcroft-Gault equation, in the determination of the dosage of direct oral anticoagulants in patients with non-valvular atrial fibrillation.
Sign Up to like & getrecommendations! Published in 2018 at "Medicina clinica"
DOI: 10.1016/j.medcli.2017.06.003
Abstract: BACKGROUND AND OBJECTIVE Direct oral anticoagulants (DOACs) require dose adjustment according to estimated clearance creatinine (eClCr) using the Cockcroft-Gault (CG) equation. There are discrepancies with the equations that estimate glomerular filtration rate (eGFR). We analyse… read more here.
Keywords: valvular atrial; patients non; non valvular; mdrd idms ... See more keywords
Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain.
Sign Up to like & getrecommendations! Published in 2018 at "Semergen"
DOI: 10.1016/j.semerg.2018.10.005
Abstract: OBJECTIVE In non-valvular atrial fibrillation (NVAF) with embolic risk, the guidelines recommend oral anticoagulation (OAC), although not all patients receive it. In this study, an attempt is made to identify these patients, and to study… read more here.
Keywords: atrial fibrillation; anticoagulation; risk; valvular atrial ... See more keywords
Clinical outcomes of dabigatran use in patients with non-valvular atrial fibrillation and weight >120 kg.
Sign Up to like & getrecommendations! Published in 2021 at "Thrombosis research"
DOI: 10.1016/j.thromres.2021.11.007
Abstract: BACKGROUND Patients with obesity were underrepresented in studies evaluating the safety and effectiveness of direct oral anticoagulants (DOAC) in patients with non-valvular atrial fibrillation (NVAF). This study compared clinical outcomes in patients with NVAF and… read more here.
Keywords: atrial fibrillation; use; valvular atrial; dabigatran use ... See more keywords
TRENDS AND PREDICTORS OF NOAC VERSUS WARFARIN USE FOR STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)31145-1
Abstract: Novel oral anticoagulants (NOACs) are now the mainstay of stroke prevention for non-valvular atrial fibrillation (NVAF). This study aims to identify the trends in anticoagulant (AC) prescribing and patient demographics and comorbid conditions that may… read more here.
Keywords: atrial fibrillation; valvular atrial; non valvular; stroke prevention ... See more keywords
A rapid evidence assessment of bleed-related healthcare resource utilization in publications reporting the use of direct oral anticoagulants for non-valvular atrial fibrillation
Sign Up to like & getrecommendations! Published in 2018 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2018.1543184
Abstract: Abstract Objective: Non-valvular atrial fibrillation (NVAF), a common cardiac arrhythmia, is associated with high morbidity and carries a substantial economic burden. Historically, vitamin K antagonists (VKAs; e.g. warfarin) have been used for therapy of NVAF,… read more here.
Keywords: valvular atrial; oral anticoagulants; patients receiving; non valvular ... See more keywords
Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry
Sign Up to like & getrecommendations! Published in 2019 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2019.1647735
Abstract: Abstract Aim: To analyse the effectiveness and safety of DOAC (direct oral anticoagulants) in non-valvular atrial fibrillation (NVAF) patients attending clinical practice. Methods: Retrospective study of AF patients who started treatment with DOAC from January… read more here.
Keywords: atrial fibrillation; valvular atrial; oral anticoagulants; non valvular ... See more keywords
Cost-effectiveness of targeted screening for non-valvular atrial fibrillation in the United Kingdom in older patients using digital approaches.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medical economics"
DOI: 10.1080/13696998.2023.2179210
Abstract: AIM Screening for non-valvular atrial fibrillation (NVAF) is key in identifying patients with undiagnosed disease who may be eligible for anticoagulation therapy. Understanding the economic value of screening is necessary to assess optimal strategies for… read more here.
Keywords: screening non; valvular atrial; cost; non valvular ... See more keywords